Citigroup »

Emergent BioSolutions shares owned by Citigroup

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Citigroup

Quarter filed Position value Share count Share price at filing
2011-06-30 $212k 9.4k 22.52
2011-03-31 $344k 14k 24.12

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Indl (XLI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Emergent BioSolutions

BlackRock
Vanguard Group
Marshall Wace
Charles Schwab Investment Management
BlackRock
American Century Companies
Morgan Stanley
Oak Hill Advisors
Invesco
Susquehanna International
Connor, Clark & Lunn Investment Management
D. E. Shaw & Co
Assenagon Asset Management
Dimensional Fund Advisors
Goldman Sachs Group

View all funds holding Emergent BioSolutions